Therapy Areas: Diabetes
EKF Diagnostics acquires Beep Insights technology to expand sports performance offering
13 April 2026 -

Life sciences company EKF Diagnostics Holdings plc (AIM: EKF) has acquired technology assets from Sweden-based Beep Insights AB, including its iOS and Android application designed for real-time glucose and lactate tracking in sports performance monitoring.

The Beep Insights Technology integrates data from Bluetooth-connected wearables with biomarker tracking to deliver personalised training metrics. The acquisition is expected to enhance EKF's existing Sports Performance portfolio, particularly its Lactate Scout Sport handheld analyser, which is already compatible with the application.

EKF has collaborated with Beep Insights and its chief executive officer, Peter Alex, to integrate the software and improve accessibility in determining lactate threshold and optimising training outcomes. Following completion of the transaction, Alex will join EKF to support further development, including the application of artificial intelligence in performance training.

Headquartered in Penarth, Wales, EKF Diagnostics is a global diagnostics business specialising in point-of-care analysers for haematology and diabetes. The company operates manufacturing sites in the US and Germany and serves customers in more than 120 countries.

Login
Username:

Password: